These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6488804)

  • 1. [Clofibrate and phosphate metabolism].
    Michailov ML
    Cor Vasa; 1984; 26(4):309-16. PubMed ID: 6488804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of miscleron on serum lipid parameters in atherosclerosis induced by cholesterol.
    Virág S; Dénes R; Pozsonyi T; Tury K
    Ther Hung; 1971; 19(4):148-9. PubMed ID: 4336261
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of serum lipid fractions as related to blood coagulation, fibrinolysis and platelet aggregation in cholesterol fed rabbits and in arteriosclerotic patients given clofibrate.
    Baldoni E; Egge H; Cuttin S; Murawski U; Gibelli A; Giarola P
    Farmaco Sci; 1973 Sep; 28(9):713-21. PubMed ID: 4749857
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of clofibrate on blood and tissue lipids in rats on a normal and on a cholesterol-enriched diet].
    Decoopman E; Dewailly P; Fruchart JC; Jaillard J; Sezille G
    Lille Med; 1977 Mar; 22(3):158-63, 193. PubMed ID: 853857
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats.
    Kim SJ; Bok SH; Lee S; Kim HJ; Lee MK; Park YB; Choi MS
    Toxicol Appl Pharmacol; 2005 Oct; 208(1):29-36. PubMed ID: 16164959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of clofibrate on aortic glycosamine-glycans and proteins and on serum lipid levels in experimental atherosclerosis.
    Bihari-Varga M; Fehér J; Varsányi M; Gerö S
    Acta Med Acad Sci Hung; 1973; 29(3):217-29. PubMed ID: 4270563
    [No Abstract]   [Full Text] [Related]  

  • 7. Potentiating of lipid-lowering activity of clofibrate by combining with low doses of 3-pyridylcarbinol in rats.
    Simane Z; Nowak H
    Atherosclerosis; 1974; 20(3):447-52. PubMed ID: 4429617
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of clofibrate (Miscleron) and pyridinol carbamate (Prodectin) on immunologic factors in experimental arteriosclerosis].
    Szondy E; Horváth M; Füst G; Fehér J; Link E; Gerö S
    Orv Hetil; 1979 Jun; 120(23):1391-2. PubMed ID: 492681
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma lipoprotein cholesterol levels in rats fed a diet enriched in cholesterol and cholic acid.
    Chiang MT; Chen YC; Huang AL
    Int J Vitam Nutr Res; 1998; 68(5):328-34. PubMed ID: 9789765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hyperlipidaemic diet and clofibrate treatment on rat erythrocyte lipids.
    Pelliniemi TT; Viikari J; Nieminen L
    Scand J Haematol; 1976 Aug; 17(2):117-22. PubMed ID: 968444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of polyfungin on experimental arteriosclerosis in rabbits.
    Noyszewska-Skibińska I; Hennig J; Kleniewski J
    Mater Med Pol; 1975; 7(1):8-13. PubMed ID: 1142820
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of Clofibrat on plasma lipid levels.
    Szostak WB; Cybulska B; Ruzyllo E
    Mater Med Pol; 1971; 3(4):12-4. PubMed ID: 5162168
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of VULM 1457, an ACAT inhibitor, on serum lipid levels and on real time red blood cell flow in diabetic and non-diabetic hamsters fed high cholesterol-lipid diet.
    Vojtassáková E; Syneková M; Tazká D; Mátyás S; Hózová R; Sadlonová I; Svec P
    Gen Physiol Biophys; 2007 Dec; 26(4):254-9. PubMed ID: 18281742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of zinc on cardiac and serum biochemical parameters in rabbits.
    Bhaskar M; Madhuri E; Abdul Latheef SA; Subramanyam G
    Indian J Exp Biol; 2001 Nov; 39(11):1170-2. PubMed ID: 11906114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of onion in induced atherosclerosis in rabbits: I. Reduction of arterial lesions and lipid levels.
    Vatsala TM; Singh M; Murugesan RG
    Artery; 1980; 7(6):519-30. PubMed ID: 7236020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probucol-lipid pharmacology.
    Kritchevsky D
    Artery; 1982; 10(1):1-6. PubMed ID: 6807261
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of clofibrate on plasma lipid concentration and liver malic enzyme gene expression in rats with experimental chronic renal failure.
    Korczyńska J; Stelmańska E; Nieweglowski T; Szołkiewicz M; Rutkowski B; Swierczyński J
    Pol J Pharmacol; 2000; 52(4):291-7. PubMed ID: 11345485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of clofibrate on cholesterol metabolism.
    Kudchodkar BJ; Sodhi HS; Horlick DL; Mason DT
    Clin Pharmacol Ther; 1977 Aug; 22(2):154-63. PubMed ID: 884917
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cholesterol and lipid lowering effects and vascular action of p-chlororphenoxy-alpha-isobutyrate of 3-hydroxymethyl-pyridine-hydrochloric acid (clofinol)].
    Marmo E; Caputi AP; Vacca C; Imperatore A; Cataldi S
    Clin Ter; 1974 Mar; 68(6):519-67. PubMed ID: 4831379
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypolipidemic effects of S-methylmethionine (vitamin U) using various experimental procedures.
    Seri K; Matsuo T; Taniguchi T; Amemiya K; Kudo M; Saito G; Kato T
    Arzneimittelforschung; 1980; 30(10):1694-703. PubMed ID: 7192109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.